BAP1 and neoplasm: Larger tumours are more likely to harbour many of the risk factors associated with worse outcomes including BAP1 mutations, vasculogenic mimicry and M3 (Kim et al., 2019; Marathe et al., 2011; Szalai et al., 2018).